Mutations in desmosomal protein genes and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20129282)

Published in Heart Rhythm on October 27, 2009

Authors

Jeffrey E Saffitz, Calum A Macrae

Articles by these authors

(truncated to the top 100)

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71

Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature (2010) 6.69

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol (2005) 5.80

A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med (2009) 4.54

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13

Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm (2004) 3.54

Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) 2.95

Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res (2002) 2.94

Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol (2010) 2.87

Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res (2004) 2.66

A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit. Am J Clin Pathol (2011) 2.58

Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A (2004) 2.32

Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation (2005) 2.29

Electrical propagation in synthetic ventricular myocyte strands from germline connexin43 knockout mice. Circ Res (2004) 2.25

3D MRI-based multicomponent FSI models for atherosclerotic plaques. Ann Biomed Eng (2004) 2.17

c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res (2002) 2.11

The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. Development (2011) 2.11

Relative contributions of connexins 40 and 43 to atrial impulse propagation in synthetic strands of neonatal and fetal murine cardiomyocytes. Circ Res (2006) 1.97

A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2007) 1.91

Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm (2012) 1.91

Local maximal stress hypothesis and computational plaque vulnerability index for atherosclerotic plaque assessment. Ann Biomed Eng (2005) 1.89

Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation. Heart Rhythm (2009) 1.87

Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm (2010) 1.85

Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol (2004) 1.82

A call to action: training pathology residents in genomics and personalized medicine. Am J Clin Pathol (2010) 1.81

Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet (2005) 1.80

Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm (2009) 1.78

Mechanoelectrical feedback as novel mechanism of cardiac electrical remodeling. Circulation (2007) 1.57

Matrix-protein-specific regulation of Cx43 expression in cardiac myocytes subjected to mechanical load. Circ Res (2005) 1.55

Protein kinase Cepsilon mediates salutary effects on electrical coupling induced by ischemic preconditioning. Heart Rhythm (2007) 1.54

A novel desmocollin-2 mutation reveals insights into the molecular link between desmosomes and gap junctions. Heart Rhythm (2011) 1.54

Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail (2012) 1.51

AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development (2008) 1.44

Impulse propagation in synthetic strands of neonatal cardiac myocytes with genetically reduced levels of connexin43. Circ Res (2003) 1.44

Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca(2+) channel. Nature (2010) 1.40

End stage of arrhythmogenic cardiomyopathy with severe involvement of the interventricular septum. Heart Rhythm (2012) 1.40

Quantifying effects of plaque structure and material properties on stress distributions in human atherosclerotic plaques using 3D FSI models. J Biomech Eng (2005) 1.38

Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res (2002) 1.34

Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. J Am Coll Cardiol (2005) 1.32

Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26

Systematic approaches to toxicology in the zebrafish. Annu Rev Pharmacol Toxicol (2011) 1.25

2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24

Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study. Eur Heart J (2012) 1.24

Echocardiographic evaluation of ventricular remodeling in a mouse model of myocardial infarction. J Am Soc Echocardiogr (2002) 1.24

Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol (2005) 1.23

Distinct pathways regulate expression of cardiac electrical and mechanical junction proteins in response to stretch. Circ Res (2005) 1.18

Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant (2007) 1.18

Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res (2003) 1.17

Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.12

Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.11

Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem (2004) 1.07

Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol (2003) 1.06

An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential. Circulation (2013) 1.06

Transmural distribution of connexins in rodent hearts. J Cardiovasc Electrophysiol (2004) 1.05

Dramatic accumulation of triglycerides and precipitation of cardiac hemodynamic dysfunction during brief caloric restriction in transgenic myocardium expressing human calcium-independent phospholipase A2gamma. J Biol Chem (2007) 1.05

Redistribution of connexin45 in gap junctions of connexin43-deficient hearts. Cardiovasc Res (2002) 1.03

Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death. Circulation (2011) 1.00

Cardiac ischemia activates calcium-independent phospholipase A2beta, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. J Biol Chem (2003) 1.00

Prolonged RV endocardial activation duration: a novel marker of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm (2009) 0.98

Fatty acid synthase modulates homeostatic responses to myocardial stress. J Biol Chem (2011) 0.98

Reduced apelin levels in lone atrial fibrillation. Eur Heart J (2005) 0.97

Diminished zonula occludens-1 expression in the failing human heart. Cardiovasc Pathol (2007) 0.96

Chondroitin sulfate expression is required for cardiac atrioventricular canal formation. Dev Dyn (2009) 0.95

Zebrafish genetic models for arrhythmia. Prog Biophys Mol Biol (2009) 0.93

The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart. Prog Biophys Mol Biol (2012) 0.92

Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations. Cardiovasc Res (2010) 0.92

Genomic oncology education: an urgent need, a new approach. Cancer J (2014) 0.92

Gap junction remodeling in a case of arrhythmogenic right ventricular dysplasia due to plakophilin-2 mutation. J Cardiovasc Electrophysiol (2008) 0.91

Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol (2013) 0.91

Remodeling of gap junctions and slow conduction in a mouse model of desmin-related cardiomyopathy. Cardiovasc Res (2005) 0.90

Electrical coupling and propagation in engineered ventricular myocardium with heterogeneous expression of connexin43. Circ Res (2012) 0.88

The genetics of atrial fibrillation. J Cardiovasc Electrophysiol (2003) 0.88

Quantitative assessment of coronary artery plaque vulnerability by high-resolution magnetic resonance imaging and computational biomechanics: a pilot study ex vivo. Magn Reson Med (2005) 0.88

Unique epidermolytic bullous dermatosis with associated lethal cardiomyopathy related to novel desmoplakin mutations. J Cutan Pathol (2008) 0.87

Novel missense mutations in exon 15 of desmoglein-2: role of the intracellular cadherin segment in arrhythmogenic right ventricular cardiomyopathy? Heart Rhythm (2010) 0.87

Gap junctions and arrhythmogenic cardiomyopathy. Heart Rhythm (2011) 0.86

Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis. Rheumatology (Oxford) (2013) 0.85

Desmosome mutations in arrhythmogenic right ventricular cardiomyopathy: important insight but only part of the picture. Circ Cardiovasc Genet (2009) 0.85

Hadp1, a newly identified pleckstrin homology domain protein, is required for cardiac contractility in zebrafish. Dis Model Mech (2011) 0.85

Cardiac structure and function in young and senescent mice heterozygous for a connexin43 null mutation. J Mol Cell Cardiol (2002) 0.84

An in vivo zebrafish screen identifies organophosphate antidotes with diverse mechanisms of action. J Biomol Screen (2012) 0.83

Splicing and dilated cardiomyopathy one gene to rule them all? J Am Coll Cardiol (2009) 0.83

Gap junctions, slow conduction, and ventricular tachycardia after myocardial infarction. J Am Coll Cardiol (2012) 0.83

Sympathetic neural activity and the pathogenesis of sudden cardiac death. Heart Rhythm (2007) 0.82

The developmental basis of adult arrhythmia: atrial fibrillation as a paradigm. Front Physiol (2013) 0.82

Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele. Cardiovasc Pathol (2011) 0.81

miR-21 represses Pdcd4 during cardiac valvulogenesis. Development (2013) 0.81

Distinct troponin C isoform requirements in cardiac and skeletal muscle. Dev Dyn (2010) 0.81

The role of endomyocardial biopsy in ARVC: looking beyond histology in search of new diagnostic markers. J Cardiovasc Electrophysiol (2010) 0.81

Remodeling of cell-cell junctions in arrhythmogenic cardiomyopathy. Cell Commun Adhes (2014) 0.80

Long QT syndrome. Circulation (2014) 0.80

Connexins, conduction, and atrial fibrillation. N Engl J Med (2006) 0.80

Is CaMKII a therapeutic target for ventricular rate control? Heart Rhythm (2005) 0.79

Reduced plakoglobin immunoreactivity in arrhythmogenic cardiomyopathy: methodological considerations. Cardiovasc Pathol (2013) 0.78

Spontaneous and inducible ventricular arrhythmias after myocardial infarction in mice. Cardiovasc Pathol (2004) 0.78

Association of the long QT syndrome With goiter and deafness. Am J Cardiol (2010) 0.77

Revisiting risk stratification in hypertrophic cardiomyopathy: do we need to start from scratch? Heart Rhythm (2011) 0.77

Optical mapping in the developing zebrafish heart. Pediatr Cardiol (2012) 0.77

Non-ischemic left ventricular dysfunction after pediatric cardiac transplantation: treatment with plasmapheresis and OKT3. J Heart Lung Transplant (2004) 0.76

Structural heart disease, SCN5A gene mutations, and Brugada syndrome: a complex ménage à trois. Circulation (2005) 0.76